"Chronic Obstructive Pulmonary Disease Market Insight, Epidemiology and Market Forecast - 2034"The chronic obstructive ...

People with schizophrenia are more likely to develop chronic obstructive pulmonary disease (COPD), suggesting a possible ...

Researchers have found a promising treatment breakthrough for chronic obstructive pulmonary disease (COPD) that avoids many ...

Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

The recent clinical study update from Regeneron Pharmaceuticals and Sanofi focuses on the investigation of Itepekimab, an anti-IL-33 monoclonal antibody, to understand its effects ...

Researchers have found a promising treatment breakthrough for Chronic Obstructive Pulmonary Disease (COPD) that avoids many drawbacks of current ...

The top 5 most-read chronic obstructive pulmonary disease (COPD) articles of 2024 covered topics such as inhaled medication risks, gabapentinoid use, and the link between high white blood cell ...

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade.

In the first half of 2024, many posts on X, formerly Twitter, from U.S. health care professionals discussing COPD therapies focused on ventilation support, medications and palliative care ...

Pulmonology > COPD Certain Diabetes Medications May Ease COPD — Propensity-matched data support another benefit of two drug classes by Crystal Phend, Contributing Editor, MedPage Today February ...

This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes.